Sarah Cannon Research Institute
Matthew Turner is an accomplished professional in clinical project management and regulatory operations, currently serving as the Associate Director of Project Management & Clinical Affairs at Sarah Cannon Research Institute since June 2022. Previously, Matthew held roles including Senior Manager of Clinical Project Administration and Manager of Site Start-Up at Sarah Cannon Development Innovations, where operational oversight was a key focus. With experience dating back to 2016 at Sarah Cannon Research Institute as a Site Support Specialist, Matthew has developed expertise in regulatory requirements and site-level support, ensuring compliance with FDA and GCP standards. Matthew's earlier positions include a Research Assistant role at OPKO Health, contributing to cancer research, and leadership roles in retail management. Matthew earned a Bachelor of Science in Biology, Pre-medicine from Belmont University in 2011.
This person is not in the org chart
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.